Related Experiment Video

Updated: Mar 17, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.1K

[Interdisciplinary differential treatment of structural heart disease : When operation and when catheter-based

S Yücel1, H Ince2,3,4, S Kische1,5

  • 1Herzzentrum, Med. Klinik I - Kardiologie, Universitätsmedizin Rostock, Ernst-Heydemann-Straße 6, 18057, Rostock, Deutschland.

Herz
|July 28, 2016
PubMed

Insights

Minimally invasive options are crucial for elderly patients with aortic valve stenosis and mitral regurgitation due to high surgical risks. Advances in transcatheter aortic valve implantation (TAVI) and new mitral valve devices offer improved outcomes and expanded treatment possibilities.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Medicine

Background:

  • Societal demographic shifts increase the prevalence of aortic valve stenosis and mitral regurgitation.
  • An aging population presents with higher rates of multimorbidity, leading to increased surgical risk and contraindications for traditional surgery.
  • Minimally invasive therapeutic options are becoming increasingly vital for managing these complex patient groups.

Purpose of the Study:

  • To review the current landscape and future directions of minimally invasive treatments for aortic valve stenosis and mitral regurgitation.
  • To highlight the importance of a multidisciplinary heart team approach in optimizing patient selection and therapeutic success.
  • To discuss the impact of next-generation transcatheter aortic valve implantation (TAVI) systems and emerging mitral valve devices.

Main Methods:

  • Review of current literature on minimally invasive cardiac procedures.
  • Analysis of trends in transcatheter aortic valve implantation (TAVI) and novel mitral valve device development.
  • Emphasis on the role of multidisciplinary heart teams in patient management.

Main Results:

  • Transcatheter aortic valve implantation (TAVI) systems are evolving, promising better outcomes, reduced complications, and lower mortality.
  • There is a clear trend towards expanding indications for TAVI.
  • Innovative minimally invasive mitral valve devices are in clinical trials, poised to shape future therapeutic strategies.

Conclusions:

  • Minimally invasive approaches, particularly TAVI, are expanding treatment options for high-risk patients with aortic and mitral valve disease.
  • Continued innovation in device technology and a collaborative heart team approach are essential for improving patient care.
  • Future therapies will likely involve further refinement of minimally invasive techniques for both aortic and mitral valve conditions.

Keywords:
Aortic valve stenosisCardiac surgical proceduresMitral valve insufficiencyMultidisciplinary heart teamTranscatheter aortic valve implantation

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.2K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.4K

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.0K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.2K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
499
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
506